Longtime Healthcare Expert to Lead External Control Arms and Innovative Research Study Models
Boston, MA, December 5, 2019—ConcertAI announced today that Craig White, PhD, has joined the company as Senior Vice President and General Manager of Outcomes Science and Services (OS&S). Dr. White brings more than 20 years of in health economic outcomes, market access, and clinical development studies.
In recent years, ConcertAI has emerged as the leader in Real-World Data (RWD) and AI technology solutions for precision oncology. The company’s singular mission is to transform healthcare by revolutionizing research models, accelerate insights benefitting patients, and bringing an array of solutions supporting the entire patient treatment journey.
ConcertAI’s Outcomes Sciences group is pioneering industry-leading Real-world Data (RWD)nretrospective and prospective studies and bringing RWD to regulatory submissions as External Control Arms and post-approval RWD studies with potential regulatory intent. In the coming months, ConcertAI will be integrating its RWD products and eurekaHealth 3.0 solution into OS&S to provide predictive models, virtual registries, and a novel “subscription study” model for HEOR and epidemiological studies.
“Craig is a forward-focused leader, who brings a valuable combination of deep experience and relentlessness to find meaningful and actionable insights that can accelerate needed therapeutic innovations for patients’ highest unmet needs,” said Jeff Elton, PhD and CEO of ConcertAI. “As we look towards the future catalyzed by the 21stCentury Cures Act and the recent FDA encouragement to advance RWD as part of submissions and to inform study designs, I am excited to have Craig as a key member of our team.”
Previously, Dr. White held leadership roles at Precision Medicine Group, where he was Vice President and Managing Director of the Health Economics and Outcomes Research group. Prior to that, he was at IQVIA where he served on the Enterprise Solutions Team for Real World Insights and led marquee initiatives in digital health and value-based pricing. Dr. White has a PhD in Health Policy from Harvard University and a BE in Electrical and Electronic Engineering from the University of Auckland.
“ConcertAI has emerged as the leader in developing previously unavailable RWD solutions and matching these to the latest data science insights tools,” said Dr. White. “My entire career has been focused on accelerating the clinical development process and advancing lifesaving medicines more quickly and efficiently. I’m privileged and thrilled to be joining the ConcertAI team at this pivotal time, and excited about the possibilities.”